过敏中的争议:我应该将ICS与SABA或Formoterol结合起来进行缓解疗法吗?
Kelsey A Finkel1, Rini Patadia2, Alan P Baptist1
1Division of Allergy and Immunology, Department of Medicine, Henry Ford Health, Detroit, Mich.
The journal of allergy and clinical immunology. In practice
|April 18, 2025
概括
对喘的抗炎缓解剂 (AIR) 治疗结合了吸入性皮质类固醇 (ICS) 和支气管扩展剂. 本综述涵盖了AIR策略,它们在减少喘恶化中的有效性,以及实施考虑.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘治疗包括各种吸入器疗法,包括用于炎症的吸入性皮质类固醇 (ICS) 和用于平滑肌肉放松的支气管扩展剂.
- 抗炎缓解剂 (AIR) 治疗将ICS与急性支气管扩展剂集成为救援用途,在减少喘恶化方面表现出有效性.
- 目前的单片吸入器选择包括ICS短效β2激动剂 (SABA) 和ICS-formoterol,以及单独的吸入器组合.
研究的目的:
- 审查有关成人和儿童群体喘抗炎缓解剂 (AIR) 治疗的现有文献.
- 讨论医疗保健提供者在为个人患者选择AIR策略时面临的实施考虑因素和挑战.
主要方法:
- 对喘管理中的抗炎缓解剂 (AIR) 治疗研究的文献综述.
- 分析不同的AIR策略,包括单吸入器组合 (ICS-SABA,ICS-formoterol) 和单独吸入器方法.
- 检查影响治疗选择的因素,如保险和监管问题.
主要成果:
- 几种 AIR 策略在缓解喘恶化方面表现出有效性.
- 该审查确定了两个主要的单吸入器组合:ICS-SABA和ICS-formoterol.
- 临床实施的挑战包括患者特异性因素,保险和监管障碍.
结论:
- AIR疗法通过结合抗炎和支气管扩展效应,为喘管理提供了有效的选择.
- 选择最佳的AIR策略需要仔细考虑疗效,患者需求和实际实施因素.
- 进一步的研究和临床指导对于优化在不同喘群体中选择和使用AIR治疗是有价值的.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
2.1K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K
Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
2.1K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Inhaled Medications
1.1K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K


